REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 96 filers reported holding REGULUS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $202,000 | +165.8% | 23,400 | +101.7% | 0.00% | – |
| Q3 2015 | $76,000 | -56.8% | 11,600 | -32.2% | 0.00% | -100.0% |
| Q2 2015 | $176,000 | -44.3% | 17,100 | -5.5% | 0.00% | -50.0% |
| Q1 2015 | $316,000 | +3.3% | 18,100 | -5.2% | 0.00% | 0.0% |
| Q4 2014 | $306,000 | +152.9% | 19,100 | +5.5% | 0.00% | +100.0% |
| Q3 2014 | $121,000 | -16.6% | 18,100 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $145,000 | -56.6% | 18,000 | -51.4% | 0.00% | -50.0% |
| Q1 2014 | $334,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |